News & Events - May 26th, 2020
4P-Pharma appoints Patrice Denèfle as Chief Scientific Officer
4P-Pharma, a biotechnology company specialised in the sourcing and the development of early stage therapeutic molecules, announces the appointment of Patrice Denèfle, PhD, HDR, Adjunct Prof., as its Chief Scientific Officer (CSO). “We are delighted to welcome Patrice to our team as Chief Scientific Officer. […] I look forward to work closely with him to&hellip